Stock EYEN EYENOVIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eyenovia, Inc.

Equities

EYEN

US30234E1047

Real-time Estimate Cboe BZX
Other stock markets
 11:36:09 2024-04-30 am EDT 		5-day change 1st Jan Change
0.781 USD +9.66% Intraday chart for Eyenovia, Inc. +43.94% -62.45%
Apr. 25 Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension CI
Apr. 08 Eyenovia to Weigh Potential Sale, Other Strategic Alternatives MT

Evolution of the average Target Price on Eyenovia, Inc.

Price target over the last 5 years

History of analyst recommendation changes

faf6ac560.qP6Uuh_aYjbdflmN01cgesfprzlWK99sM0SDOwmzpCk.3pij0nmtFFTlGzDkhWNXPaKPxnMGf_IaBhLTb0P_4WT5kNKMdLQbTJAMYQ~76c12547a74b582e362f402e1a1a2932

Analyst Recommendations on Eyenovia, Inc.

William Blair Initiates Eyenovia at Outperform Rating MT
HC Wainwright Starts Eyenovia at Buy With $12 Price Target MT
Northland Adjusts Eyenovia's Price Target to $9 From $12, Maintains Outperform Rating MT
EYENOVIA : HC Wainwright Adjusts Price Target on Eyenovia to $8 From $6, Maintains Buy Rating MT
EYENOVIA : Northland Starts Eyenovia at Outperform With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.7122 USD
Average target price
9.333 USD
Spread / Average Target
+1,210.49%
High Price Target
12 USD
Spread / Highest target
+1,584.92%
Low Price Target
6 USD
Spread / Lowest Target
+742.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eyenovia, Inc.

William Blair & Co.
HC Wainwright
Northland Securities

Ratings for Eyenovia, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EYEN Stock
  4. Consensus Eyenovia, Inc.